Company news

Fosun International Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Announcement - passing of joint company secretary

November 2, 2026

Announcement - principal financial data of fosun high technology for the nine months ended 30 September 2026

October 30, 2026

Announcement - principal financial data of yuyuan for the nine months ended 30 September 2026

October 29, 2026

Fosun International Wins Five Awards at The Asset Corporate Sustainability Leadership Awards 2026, Upgraded to Platinum

October 13, 2026

Monthly return as at 30 September 2026

October 6, 2026

List of directors and their roles and functions

September 24, 2026

Appointment of non-executive director

September 24, 2026

Interim report 2026

September 22, 2026

Club med inaugurates its first resort in south africa, pioneering a new beach & safari experience

September 21, 2026

ClubMed Lifestyle Group Advances Global Expansion Through Industry Collaboration and AI Application

September 8, 2026

Hang Seng Sustainability Rating Climbs to AA+, Setting a New Record

September 7, 2026

Fosun International's Hang Seng Sustainability Rating Climbs to AA+, Setting a New Record

September 7, 2026

Fosun International Holds 2026 Interim Results Presentation: Unlocking Core Pathways, Accelerating Growth in Industries where we Excel

August 31, 2026

Fosun International: Henlius’ Serplulimab Approved for Perioperative Gastric Cancer, Pioneering a Chemotherapy-Sparring Adjuvant Approach

June 9, 2026

Fosun International: Henlius' Pertuzumab Approved in China, Solidifying Breast Cancer Strategy as the First China-US-EU Approved Chinese Trastuzumab-Pertuzumab Combination

May 28, 2026

Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer’s Disease

May 14, 2026

Fosun International: Henlius’ HLX43 (anti-PD-L1 ADC) Receives PMDA’s Acknowledge to Initiate Global Phase 2/3 Trial in sqNSCLC

May 8, 2026

ESG Report 2025

April 28, 2026

Fosun International: Total Revenue in 2025 Reaches RMB173.43 Billion, with Overseas Revenue Accounting for 54.7%，Aiming to Achieve“RMB10 Billion in Profit”

March 30, 2026

Fosun International and HSBC China Sign Strategic Cooperation Agreement

March 13, 2026

Fosun Navigates Cyclical Volatility and Clears Risks as Management Reaffirms RMB10 Bn Profit Target for Next 3 to 5 Yrs

March 12, 2026

Fosun International: One-Off Non-Cash Impairment Provisions for Certain Non-Core Businesses, Core Industries Maintain Sound Development Momentum

March 9, 2026

Fosun International Receives “Certificate of Excellence in Environmental, Social and Governance Reporting” from Hong Kong Management Association

February 26, 2026

Fosun International Honored as “ESG Leading Enterprise” by Bloomberg Businessweek/Chinese Edition

November 21, 2025

Fosun International: Henlius Completes Patient Enrolment in the U.S. Bridging Study of Serplulimab in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

October 23, 2025

Fosun International Signs Strategic Cooperation Agreement with BNP Paribas

October 13, 2025

S&P Global CSA Score Rises to 72, Retains Industry Lead

October 9, 2025

Fosun International Achieves AA- in HSI ESG Rating for Third Consecutive Year, Marks Sixth Year as Constituent of Hang Seng Corporate Sustainability Benchmark Index

September 14, 2025

Holds Signing Ceremony for USD910 Million Equivalent Syndicated Loan, Underscoring Global Market Confidence in its Future Development

September 10, 2025

Pharma Gains Exclusive Rights for Accro's Novel Small-Molecule Drug Candidate AC-201 in Greater China

September 1, 2025

Fosun International: Hosts 2025 Interim Results Presentation, Reaffirms Confidence in Future Development Driven by Innovation and Globalization

August 29, 2025

Decks

The 5 newest of 9 decks. Every deck is listed under its year.